Umme Hani Khuddus, MD
Obstetrics/Gynecology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Khuddus’s office at (408) 340-5700 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A106144 · Current
Licensed to practise in California · since 2008 · expires 2028-01-31 · Bangalore University, M.S. Ramaiah Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$131,827
Medicare paid this office $131,827 for 354 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 210 | $44,587 | $107 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 140 | $21,431 | $153 |
| Short return visit (20+ min) | 212 | $20,998 | $73 |
| Sarscov2 vac 50 mcg/0.5ml im | 62 | $10,009 | $152 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 233 | $6,066 | $14 |
See all 16 services
| Return visit (30+ min) | 210 | $44,587 | $107 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 140 | $21,431 | $153 |
| Short return visit (20+ min) | 212 | $20,998 | $73 |
| Sarscov2 vac 50 mcg/0.5ml im | 62 | $10,009 | $152 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 233 | $6,066 | $14 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 13 | $3,760 | $289 |
| Influenza vaccine split virus, preservative free | 41 | $3,479 | $81 |
| Admn sarscov2 vacc 1 dose | 62 | $3,439 | $52 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 22 | $1,987 | $48 |
| Administration of influenza virus vaccine | 44 | $1,758 | $38 |
| Short return visit | 34 | $1,269 | $37 |
| Removal of impacted ear wax | 20 | $635 | $30 |
| Administration of pneumococcal vaccine | 13 | $497 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $225 | $9 |
| Hemoglobin a1c level | 19 | $219 | $10 |
| Automated urinalysis test | 11 | $24 | $2 |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
354 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 12% · Women 65% · Also on Medicaid 10% · Health risk score 1.07. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 66% · Diabetes 23% · Coronary heart disease 23% · Depression 19% · Chronic kidney disease 17% · Cancer 14% · Atrial fibrillation 12% · Heart failure 11% · COPD 8% · Dementia 8% · Stroke 8%.
The office billed $457,692, Medicare allowed $170,298 and paid $131,827; for 2,054 services of 53 kinds; $19,719 of it was for drugs given in the office and $112,107 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 354 | 2,054 | 75 | 1.07 | $457,692 | $131,827 |
| 2023 | 375 | 1,669 | 74 | 1.00 | $437,038 | $130,725 |
| 2022 | 241 | 552 | 74 | 1.08 | $148,935 | $47,405 |
| 2021 | 131 | 349 | 73 | 0.79 | $88,660 | $26,739 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Return visit (30+ min) | 208 | $40,314 | $116 |
| Short return visit (20+ min) | 185 | $20,365 | $79 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 50 | $14,072 | $281 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 86 | $13,720 | $160 |
| New patient visit (45+ min) | 43 | $6,194 | $144 |
| Influenza vaccine split virus, preservative free | 72 | $5,179 | $72 |
| Administration of influenza virus vaccine | 75 | $2,837 | $38 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 14 | $2,822 | $202 |
| Sarscov2 vac 50 mcg/0.5ml im | 18 | $2,574 | $143 |
| Administration of pneumococcal vaccine | 49 | $1,853 | $38 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 21 | $1,590 | $51 |
| New patient visit (30+ min) | 17 | $1,543 | $91 |
| Adm sarscv2 bvl 30mcg/.3ml a | 30 | $1,513 | $50 |
| Admn sarscov2 vacc 1 dose | 18 | $908 | $50 |
| Short return visit | 17 | $852 | $50 |
| Removal of impacted ear wax | 18 | $683 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 33 | $334 | $10 |
| Hemoglobin a1c level | 17 | $195 | $9 |
| Automated urinalysis test | 18 | $44 | $2 |
2022: 11 services
| Short return visit (20+ min) | 130 | $12,275 | $79 |
| Return visit (30+ min) | 71 | $9,665 | $118 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 38 | $5,995 | $158 |
| Influenza vaccine split virus, preservative free | 39 | $2,659 | $68 |
| Long return visit (40+ min) | 13 | $2,298 | $177 |
| Administration of influenza virus vaccine | 47 | $1,752 | $37 |
| New patient visit (45+ min) | 11 | $1,730 | $157 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $986 | $49 |
| Short return visit | 15 | $688 | $43 |
| Adm sarscv2 bvl 30mcg/.3ml a | 12 | $593 | $49 |
| Administration of pneumococcal vaccine | 11 | $411 | $37 |
2021: 8 services
| Return visit (30+ min) | 49 | $7,251 | $134 |
| Short return visit (20+ min) | 35 | $3,117 | $78 |
| New patient visit (60+ min) | 12 | $2,806 | $234 |
| Influenza vaccine split virus, preservative free | 39 | $2,545 | $65 |
| Long return visit (40+ min) | 11 | $2,109 | $176 |
| Pneumococcal vaccine, 23-valent | 12 | $1,511 | $126 |
| Administration of influenza virus vaccine | 46 | $994 | $22 |
| Administration of pneumococcal vaccine | 12 | $259 | $22 |
Medicaid work
$1,177,699 in 2021
Medicaid paid $1,177,699 for 12,666 billed services this clinician did in 2021, up to 588 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 4,578 | $1,156,008 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 75 | $4,934 |
| Short return visit (20+ min) | 4,535 | $4,363 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 94 | $2,607 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 79 | $2,116 |
| Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 41 | $1,366 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 142 | $1,147 |
| Return visit (30+ min) | 1,068 | $1,081 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 130 | $1,013 |
| Pure tone audiometry (threshold); air only | 140 | $902 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 76 | $649 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 41 | $628 |
| 2021 | 12,666 | 36 | 588 | $1,177,699 |
| 2020 | 17,227 | 46 | 639 | $873,796 |
| 2019 | 22,308 | 42 | 581 | $1,461,793 |
| 2018 | 21,461 | 29 | 784 | $1,978,662 |
See the largest Medicaid services in earlier years
2020
| Clinic visit/encounter, all-inclusive | 4,764 | $826,347 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 229 | $13,203 |
| Long return visit (40+ min) | 104 | $7,466 |
| Short return visit (20+ min) | 5,613 | $5,303 |
| Return visit (30+ min) | 1,231 | $3,682 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 15 minutes | 326 | $2,808 |
| Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 284 | $2,412 |
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 16 | $2,072 |
| Pure tone audiometry (threshold); air only | 166 | $1,914 |
| Health and behavior assessment (eg, health-focused clinical interview, behavioral observations, psychophysiological monitoring, health-oriented questionnaires), each 15 minutes face-to-face with the patient; re-assessment | 149 | $1,353 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 57 | $936 |
| OFF/OP EST MAY X REQ PHY/QHP | 671 | $821 |
2019
| Clinic visit/encounter, all-inclusive | 9,460 | $1,371,831 |
| Short return visit (20+ min) | 4,299 | $48,441 |
| Return visit (30+ min) | 1,785 | $13,367 |
| New patient visit (30+ min) | 101 | $5,708 |
| Pure tone audiometry (threshold); air only | 652 | $3,383 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 183 | $2,533 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 62 | $2,278 |
| Long return visit (40+ min) | 220 | $2,070 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 176 | $1,604 |
| Comprehensive multidisciplinary evaluation | 14 | $1,456 |
| Short return visit | 319 | $1,199 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 94 | $1,160 |
2018
| Clinic visit/encounter, all-inclusive | 13,235 | $1,855,858 |
| Short return visit (20+ min) | 3,714 | $70,401 |
| Return visit (30+ min) | 1,244 | $15,794 |
| New patient visit (30+ min) | 131 | $14,827 |
| Pure tone audiometry (threshold); air only | 379 | $4,777 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 43 | $2,263 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation | 30 | $2,164 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 82 | $1,851 |
| Short return visit | 391 | $1,692 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 212 | $1,266 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 132 | $1,176 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 15 minutes | 89 | $874 |
Drugs they prescribed that Part D paid
$308,872
Pharmacies billed $308,872 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (70 of 4,269) in 2024. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
3,775 generic and 482 brand-name prescriptions · $308,872 in drug cost · 70 antibiotic prescriptions to 54 people · 16 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 17 | $24,842 | $1,461 |
| Mounjaro | 22 | $22,872 | $1,040 |
| Eliquis | 18 | $22,111 | $1,228 |
| Ozempic | 12 | $17,142 | $1,429 |
| Farxiga | 11 | $9,463 | $860 |
See all 94 drugs
| Jardiance | 17 | $24,842 | $1,461 |
| Mounjaro | 22 | $22,872 | $1,040 |
| Eliquis | 18 | $22,111 | $1,228 |
| Ozempic | 12 | $17,142 | $1,429 |
| Farxiga | 11 | $9,463 | $860 |
| Praluent | 13 | $6,229 | $479 |
| Symbicort | 21 | $5,712 | $272 |
| Synthroid | 44 | $3,179 | $72 |
| Atorvastatin | 302 | $2,647 | $9 |
| Celecoxib | 37 | $2,440 | $66 |
| Levothyroxine | 198 | $2,182 | $11 |
| Estradiol | 41 | $2,176 | $53 |
| Gabapentin | 111 | $2,174 | $20 |
| Albuterol Sulfate Hfa | 66 | $2,083 | $32 |
| Rosuvastatin | 133 | $1,653 | $12 |
| Losartan | 199 | $1,640 | $8 |
| Wixela Inhub | 15 | $1,441 | $96 |
| Metoprolol | 80 | $1,397 | $17 |
| Escitalopram | 77 | $1,307 | $17 |
| Amlodipine Besylate | 174 | $1,237 | $7 |
| Omega-3 Acid Ethyl Esters | 25 | $1,114 | $45 |
| Duloxetine | 41 | $1,104 | $27 |
| Hydrocodone-Acetaminophen | 39 | $1,081 | $28 |
| Telmisartan | 32 | $894 | $28 |
| Tolterodine | 11 | $824 | $75 |
| Alendronate | 67 | $753 | $11 |
| Solifenacin | 21 | $751 | $36 |
| Bupropion Hcl Sr | 26 | $744 | $29 |
| Ventolin Hfa | 13 | $720 | $55 |
| Ezetimibe | 17 | $705 | $41 |
| Lisinopril | 61 | $698 | $11 |
| Pregabalin | 27 | $681 | $25 |
| Valsartan-Hydrochlorothiazide | 12 | $634 | $53 |
| Tamsulosin | 47 | $622 | $13 |
| Diclofenac | 25 | $622 | $25 |
| Simvastatin | 61 | $570 | $9 |
| Losartan-Hydrochlorothiazide | 32 | $556 | $17 |
| Omeprazole | 62 | $551 | $9 |
| Propranolol Hcl Er | 14 | $549 | $39 |
| Azelastine | 12 | $538 | $45 |
| Famotidine | 41 | $498 | $12 |
| Bupropion Xl | 13 | $491 | $38 |
| Pantoprazole | 41 | $477 | $12 |
| Sertraline | 45 | $469 | $10 |
| Metformin | 83 | $465 | $6 |
| Fluticasone Propionate | 30 | $421 | $14 |
| Olmesartan Medoxomil | 21 | $420 | $20 |
| Trazodone | 75 | $389 | $5 |
| Hydrochlorothiazide | 45 | $380 | $8 |
| Carbidopa-Levodopa Er | 12 | $351 | $29 |
| Quetiapine | 25 | $342 | $14 |
| Allopurinol | 24 | $340 | $14 |
| Estradiol (Twice Weekly) | 12 | $338 | $28 |
| Pravastatin | 21 | $333 | $16 |
| Fluoxetine | 15 | $326 | $22 |
| Mirtazapine | 27 | $323 | $12 |
| Zolpidem | 42 | $302 | $7 |
| Divalproex Sodium Er | 19 | $275 | $14 |
| Metformin Hcl Er | 28 | $273 | $10 |
| Clotrimazole | 17 | $265 | $16 |
| Spironolactone | 14 | $228 | $16 |
| Potassium Chloride | 13 | $227 | $17 |
| Donepezil | 13 | $225 | $17 |
| Alprazolam | 55 | $216 | $4 |
| Atenolol | 27 | $196 | $7 |
| Lovastatin | 18 | $194 | $11 |
| Furosemide | 54 | $191 | $4 |
| Hydralazine | 21 | $190 | $9 |
| Triamcinolone Acetonide | 22 | $188 | $9 |
| Memantine | 13 | $183 | $14 |
| Tizanidine | 18 | $174 | $10 |
| Naproxen | 19 | $170 | $9 |
| Clonazepam | 20 | $166 | $8 |
| Nitrofurantoin Mono-Macro | 12 | $165 | $14 |
| Lorazepam | 36 | $164 | $5 |
| Glimepiride | 18 | $155 | $9 |
| Oxycodone | 13 | $136 | $10 |
| Ondansetron | 26 | $132 | $5 |
| Carvedilol | 16 | $125 | $8 |
| Benazepril | 16 | $117 | $7 |
| Citalopram Hbr | 23 | $112 | $5 |
| Hydrocortisone | 15 | $110 | $7 |
| Propranolol | 16 | $106 | $7 |
| Lisinopril-Hydrochlorothiazide | 13 | $95 | $7 |
| Cephalexin | 12 | $93 | $8 |
| Meloxicam | 20 | $88 | $4 |
| Montelukast | 15 | $75 | $5 |
| Acyclovir | 16 | $73 | $5 |
| Hydroxyzine | 11 | $67 | $6 |
| Azithromycin | 15 | $55 | $4 |
| Tramadol | 15 | $48 | $3 |
| Amitriptyline | 11 | $30 | $3 |
| Triamterene-Hydrochlorothiazid | 12 | $19 | $2 |
| Paxlovid | 11 | $0 | $0 |
Year by year
| 2024 | 4,269 | 482 | 2% (70) | 11% | $308,872 |
| 2023 | 3,337 | 482 | 2% (63) | 13% | $301,399 |
| 2022 | 1,397 | 303 | 2% (27) | 10% | $75,775 |
| 2021 | 2,108 | 230 | 1% (13) | 12% | $108,308 |
| 2020 | 1,929 | 145 | None | 13% | $70,963 |
| 2019 | 1,443 | 117 | None | None | $49,210 |
| 2018 | 1,424 | 118 | None | None | $56,239 |
| 2017 | 1,212 | 107 | None | None | $38,037 |
| 2016 | 1,076 | 111 | None | None | $43,753 |
| 2015 | 1,004 | 96 | None | None | $44,510 |
| 2014 | 817 | 78 | 2% (16) | None | $30,798 |
| 2013 | 550 | 64 | 4% (19) | None | $25,359 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 74 drugs
| Ozempic | 27 | $29,329 | $1,086 |
| Prolia | 14 | $23,211 | $1,658 |
| Eliquis | 21 | $15,830 | $754 |
| Jardiance | 15 | $15,498 | $1,033 |
| Symbicort | 16 | $6,677 | $417 |
| Anoro Ellipta | 11 | $4,930 | $448 |
| Breo Ellipta | 11 | $4,687 | $426 |
| Synthroid | 29 | $3,419 | $118 |
| Atorvastatin | 217 | $3,145 | $14 |
| Levothyroxine | 157 | $2,787 | $18 |
| Rosuvastatin | 108 | $2,270 | $21 |
| Losartan | 119 | $2,088 | $18 |
| Amlodipine Besylate | 197 | $1,933 | $10 |
| Propranolol Hcl Er | 19 | $1,684 | $89 |
| Estradiol | 17 | $1,613 | $95 |
| Solifenacin | 12 | $1,542 | $128 |
| Valsartan-Hydrochlorothiazide | 15 | $1,502 | $100 |
| Metoprolol | 62 | $1,462 | $24 |
| Pregabalin | 24 | $1,327 | $55 |
| Ventolin Hfa | 17 | $1,060 | $62 |
| Alendronate | 72 | $1,042 | $14 |
| Gabapentin | 75 | $1,003 | $13 |
| Omeprazole | 68 | $991 | $15 |
| Duloxetine | 28 | $964 | $34 |
| Diclofenac | 26 | $949 | $37 |
| Celecoxib | 21 | $949 | $45 |
| Albuterol Sulfate Hfa | 38 | $943 | $25 |
| Escitalopram | 41 | $942 | $23 |
| Tamsulosin | 39 | $880 | $23 |
| Simvastatin | 56 | $876 | $16 |
| Telmisartan | 24 | $786 | $33 |
| Losartan-Hydrochlorothiazide | 32 | $709 | $22 |
| Valsartan | 11 | $708 | $64 |
| Pantoprazole | 21 | $704 | $34 |
| Famotidine | 23 | $661 | $29 |
| Hydrocodone-Acetaminophen | 32 | $642 | $20 |
| Fluocinonide | 15 | $624 | $42 |
| Metformin | 64 | $610 | $10 |
| Lisinopril | 72 | $552 | $8 |
| Donepezil | 13 | $489 | $38 |
| Sertraline | 27 | $411 | $15 |
| Trazodone | 29 | $395 | $14 |
| Atenolol | 30 | $367 | $12 |
| Citalopram Hbr | 19 | $356 | $19 |
| Hydralazine | 22 | $346 | $16 |
| Metformin Hcl Er | 19 | $339 | $18 |
| Propranolol | 12 | $334 | $28 |
| Pravastatin | 16 | $334 | $21 |
| Furosemide | 35 | $329 | $9 |
| Zolpidem | 41 | $302 | $7 |
| Lorazepam | 33 | $297 | $9 |
| Montelukast | 14 | $275 | $20 |
| Allopurinol | 15 | $266 | $18 |
| Alprazolam | 57 | $265 | $5 |
| Carvedilol | 14 | $249 | $18 |
| Fluticasone Propionate | 17 | $233 | $14 |
| Hydrochlorothiazide | 52 | $231 | $4 |
| Fluoxetine | 22 | $215 | $10 |
| Lisinopril-Hydrochlorothiazide | 11 | $190 | $17 |
| Metoprolol | 17 | $187 | $11 |
| Spironolactone | 13 | $173 | $13 |
| Clotrimazole | 13 | $162 | $12 |
| Acyclovir | 17 | $161 | $9 |
| Paxlovid (Eua) | 16 | $158 | $10 |
| Clonazepam | 15 | $136 | $9 |
| Ibuprofen | 12 | $135 | $11 |
| Triamterene-Hydrochlorothiazid | 16 | $124 | $8 |
| Triamcinolone Acetonide | 16 | $121 | $8 |
| Tramadol | 19 | $118 | $6 |
| Meloxicam | 25 | $115 | $5 |
| Azithromycin | 13 | $102 | $8 |
| Cephalexin | 16 | $89 | $6 |
| Ondansetron | 15 | $84 | $6 |
| Naproxen | 17 | $65 | $4 |
2022: 38 drugs
| Eliquis | 11 | $7,792 | $708 |
| Synthroid | 14 | $1,595 | $114 |
| Celecoxib | 11 | $1,172 | $107 |
| Levothyroxine | 60 | $945 | $16 |
| Atorvastatin | 82 | $879 | $11 |
| Amlodipine Besylate | 92 | $870 | $9 |
| Metoprolol | 39 | $641 | $16 |
| Gabapentin | 36 | $614 | $17 |
| Rosuvastatin | 29 | $518 | $18 |
| Losartan-Hydrochlorothiazide | 12 | $453 | $38 |
| Losartan | 36 | $432 | $12 |
| Alendronate | 43 | $395 | $9 |
| Duloxetine | 13 | $353 | $27 |
| Tamsulosin | 22 | $352 | $16 |
| Metformin | 39 | $317 | $8 |
| Famotidine | 16 | $297 | $19 |
| Hydrocodone-Acetaminophen | 11 | $274 | $25 |
| Omeprazole | 30 | $266 | $9 |
| Paroxetine | 14 | $260 | $19 |
| Lisinopril | 39 | $260 | $7 |
| Hydralazine | 11 | $257 | $23 |
| Escitalopram | 25 | $240 | $10 |
| Pantoprazole | 11 | $219 | $20 |
| Trazodone | 18 | $213 | $12 |
| Atenolol | 20 | $203 | $10 |
| Sertraline | 23 | $197 | $9 |
| Furosemide | 20 | $171 | $9 |
| Azithromycin | 16 | $138 | $9 |
| Lorazepam | 19 | $137 | $7 |
| Zolpidem | 19 | $131 | $7 |
| Metoprolol | 11 | $130 | $12 |
| Simvastatin | 14 | $130 | $9 |
| Alprazolam | 27 | $128 | $5 |
| Paxlovid (Eua) | 12 | $107 | $9 |
| Amoxicillin | 11 | $60 | $5 |
| Metformin Hcl Er | 11 | $40 | $4 |
| Naproxen | 11 | $25 | $2 |
| Hydrochlorothiazide | 11 | $21 | $2 |
2021: 42 drugs
| Januvia | 26 | $25,849 | $994 |
| Lantus Solostar | 16 | $5,414 | $338 |
| Flovent Hfa | 11 | $3,483 | $317 |
| Levothyroxine | 113 | $1,973 | $17 |
| Atorvastatin | 140 | $1,906 | $14 |
| Losartan | 126 | $1,442 | $11 |
| Rosuvastatin | 19 | $1,277 | $67 |
| Amlodipine Besylate | 135 | $1,187 | $9 |
| Omeprazole | 86 | $974 | $11 |
| Tamsulosin | 59 | $971 | $16 |
| Albuterol Sulfate Hfa | 21 | $912 | $43 |
| Alendronate | 77 | $782 | $10 |
| Metformin | 127 | $742 | $6 |
| Diclofenac | 25 | $668 | $27 |
| Gabapentin | 53 | $604 | $11 |
| Fluticasone Propionate | 25 | $486 | $19 |
| Metoprolol | 24 | $451 | $19 |
| Atenolol | 55 | $436 | $8 |
| Glipizide Er | 40 | $421 | $11 |
| Pantoprazole | 32 | $381 | $12 |
| Famotidine | 23 | $364 | $16 |
| Lisinopril | 53 | $345 | $7 |
| Metoprolol | 24 | $336 | $14 |
| Naproxen | 34 | $253 | $7 |
| Hydrochlorothiazide | 46 | $246 | $5 |
| Clotrimazole | 13 | $244 | $19 |
| Simvastatin | 40 | $240 | $6 |
| Furosemide | 28 | $233 | $8 |
| Pravastatin | 13 | $233 | $18 |
| Glimepiride | 13 | $228 | $18 |
| Paroxetine | 18 | $219 | $12 |
| Escitalopram | 26 | $207 | $8 |
| Sertraline | 17 | $173 | $10 |
| Glipizide | 25 | $172 | $7 |
| Triamcinolone Acetonide | 19 | $169 | $9 |
| Mirtazapine | 14 | $137 | $10 |
| Allopurinol | 11 | $136 | $12 |
| Pioglitazone | 13 | $133 | $10 |
| Cyclobenzaprine | 11 | $128 | $12 |
| Citalopram Hbr | 12 | $104 | $9 |
| Carvedilol | 14 | $86 | $6 |
| Ibuprofen | 13 | $46 | $4 |
2020: 42 drugs
| Januvia | 19 | $10,361 | $545 |
| Myrbetriq | 11 | $7,681 | $698 |
| Lantus Solostar | 23 | $3,728 | $162 |
| Basaglar Kwikpen U-100 | 15 | $2,372 | $158 |
| Levothyroxine | 89 | $1,679 | $19 |
| Losartan-Hydrochlorothiazide | 12 | $1,652 | $138 |
| Losartan | 125 | $1,369 | $11 |
| Atorvastatin | 131 | $1,341 | $10 |
| Albuterol Sulfate Hfa | 29 | $1,210 | $42 |
| Diclofenac | 28 | $863 | $31 |
| Metformin | 131 | $840 | $6 |
| Tamsulosin | 55 | $751 | $14 |
| Amlodipine Besylate | 112 | $667 | $6 |
| Atenolol | 53 | $569 | $11 |
| Fluticasone Propionate | 33 | $505 | $15 |
| Metoprolol | 24 | $476 | $20 |
| Omeprazole | 65 | $470 | $7 |
| Alendronate | 50 | $467 | $9 |
| Glipizide Er | 43 | $460 | $11 |
| Hydrochlorothiazide | 53 | $298 | $6 |
| Pantoprazole | 34 | $271 | $8 |
| Pravastatin | 12 | $270 | $22 |
| Gabapentin | 28 | $239 | $9 |
| Alcohol Prep Pads | 24 | $239 | $10 |
| Metoprolol | 26 | $228 | $9 |
| Finasteride | 13 | $223 | $17 |
| Lisinopril | 40 | $223 | $6 |
| Simvastatin | 32 | $221 | $7 |
| Naproxen | 35 | $212 | $6 |
| Paroxetine | 20 | $201 | $10 |
| Triamcinolone Acetonide | 19 | $188 | $10 |
| Hydralazine | 12 | $179 | $15 |
| Cyclobenzaprine | 20 | $177 | $9 |
| Glimepiride | 11 | $172 | $16 |
| Furosemide | 27 | $153 | $6 |
| Glipizide | 23 | $152 | $7 |
| Oxybutynin Chloride | 15 | $145 | $10 |
| Sertraline | 23 | $121 | $5 |
| Escitalopram | 14 | $99 | $7 |
| Carvedilol | 21 | $94 | $4 |
| Ibuprofen | 14 | $71 | $5 |
| Citalopram Hbr | 17 | $71 | $4 |
2019: 33 drugs
| Januvia | 12 | $9,234 | $769 |
| Omega-3 Acid Ethyl Esters | 13 | $1,412 | $109 |
| Atorvastatin | 85 | $1,206 | $14 |
| Levothyroxine | 60 | $1,146 | $19 |
| Losartan | 103 | $1,104 | $11 |
| Tamsulosin | 49 | $767 | $16 |
| Ventolin Hfa | 12 | $705 | $59 |
| Amlodipine Besylate | 87 | $661 | $8 |
| Metformin | 95 | $628 | $7 |
| Omeprazole | 47 | $499 | $11 |
| Atenolol | 49 | $451 | $9 |
| Alendronate | 41 | $417 | $10 |
| Valsartan | 11 | $415 | $38 |
| Metoprolol | 17 | $408 | $24 |
| Glipizide Er | 18 | $342 | $19 |
| Fluticasone Propionate | 26 | $325 | $12 |
| Lisinopril | 46 | $281 | $6 |
| Hydralazine | 14 | $259 | $19 |
| Pantoprazole | 35 | $240 | $7 |
| Hydrochlorothiazide | 43 | $216 | $5 |
| Simvastatin | 31 | $206 | $7 |
| Metoprolol | 24 | $190 | $8 |
| Triamcinolone Acetonide | 11 | $182 | $17 |
| Glipizide Xl | 16 | $145 | $9 |
| Gabapentin | 16 | $127 | $8 |
| Oxybutynin Chloride | 14 | $125 | $9 |
| Glipizide | 15 | $124 | $8 |
| Ibuprofen | 15 | $119 | $8 |
| Cyclobenzaprine | 16 | $118 | $7 |
| Furosemide | 16 | $97 | $6 |
| Sertraline | 11 | $90 | $8 |
| Ranitidine | 11 | $89 | $8 |
| Naproxen | 13 | $81 | $6 |
2018: 35 drugs
| Januvia | 24 | $14,547 | $606 |
| Vesicare | 12 | $4,487 | $374 |
| Omega-3 Acid Ethyl Esters | 15 | $1,411 | $94 |
| Atorvastatin | 64 | $1,007 | $16 |
| Levothyroxine | 60 | $1,003 | $17 |
| Voltaren | 14 | $767 | $55 |
| Polyethylene Glycol 3350 | 13 | $738 | $57 |
| Losartan | 95 | $710 | $7 |
| Amlodipine Besylate | 83 | $619 | $7 |
| Metoprolol | 23 | $583 | $25 |
| Metformin | 81 | $529 | $7 |
| Propranolol | 14 | $458 | $33 |
| Omeprazole | 71 | $445 | $6 |
| Valsartan | 12 | $423 | $35 |
| Tamsulosin | 20 | $388 | $19 |
| Atenolol | 47 | $340 | $7 |
| Glipizide Er | 22 | $316 | $14 |
| Simvastatin | 45 | $270 | $6 |
| Cyclobenzaprine | 17 | $240 | $14 |
| Gabapentin | 18 | $226 | $13 |
| Lisinopril | 44 | $209 | $5 |
| Hydrochlorothiazide | 43 | $203 | $5 |
| Naproxen | 24 | $185 | $8 |
| Triamcinolone Acetonide | 14 | $162 | $12 |
| Metoprolol | 27 | $161 | $6 |
| Clotrimazole | 12 | $153 | $13 |
| Alendronate | 21 | $136 | $6 |
| Glipizide Xl | 11 | $131 | $12 |
| Ibuprofen | 24 | $124 | $5 |
| Glipizide | 13 | $116 | $9 |
| Fluticasone Propionate | 15 | $101 | $7 |
| Pantoprazole | 14 | $86 | $6 |
| Citalopram Hbr | 16 | $83 | $5 |
| Furosemide | 18 | $71 | $4 |
| Ranitidine | 11 | $50 | $5 |
2017: 29 drugs
| Januvia | 22 | $13,238 | $602 |
| Proctozone-Hc | 14 | $1,203 | $86 |
| Levothyroxine | 62 | $1,023 | $17 |
| Atorvastatin | 57 | $733 | $13 |
| Ventolin Hfa | 12 | $629 | $52 |
| Metformin | 93 | $567 | $6 |
| Valsartan | 15 | $559 | $37 |
| Losartan | 84 | $521 | $6 |
| Amlodipine Besylate | 74 | $519 | $7 |
| Metoprolol | 15 | $484 | $32 |
| Alendronate | 44 | $420 | $10 |
| Simvastatin | 66 | $321 | $5 |
| Tamsulosin | 15 | $279 | $19 |
| Glipizide Er | 16 | $262 | $16 |
| Atenolol | 55 | $254 | $5 |
| Omeprazole | 49 | $253 | $5 |
| Hydrochlorothiazide | 42 | $239 | $6 |
| Propranolol | 13 | $221 | $17 |
| Sulindac | 12 | $209 | $17 |
| Pioglitazone | 15 | $203 | $14 |
| Triamcinolone Acetonide | 18 | $164 | $9 |
| Pantoprazole | 12 | $150 | $12 |
| Lisinopril | 31 | $141 | $5 |
| Naproxen | 17 | $134 | $8 |
| Glipizide | 25 | $133 | $5 |
| Citalopram Hbr | 22 | $86 | $4 |
| Metoprolol | 13 | $81 | $6 |
| Ibuprofen | 15 | $74 | $5 |
| Gabapentin | 11 | $67 | $6 |
2016: 24 drugs
| Januvia | 15 | $6,795 | $453 |
| Valsartan | 18 | $4,110 | $228 |
| Bystolic | 12 | $2,614 | $218 |
| Omega-3 Acid Ethyl Esters | 30 | $2,124 | $71 |
| Amlodipine-Valsartan-Hctz | 12 | $1,431 | $119 |
| Levothyroxine | 57 | $892 | $16 |
| Metformin | 88 | $840 | $10 |
| Amlodipine Besylate | 65 | $661 | $10 |
| Simvastatin | 75 | $591 | $8 |
| Alendronate | 52 | $539 | $10 |
| Atorvastatin | 19 | $529 | $28 |
| Glipizide Er | 29 | $431 | $15 |
| Losartan | 47 | $422 | $9 |
| Hydralazine | 15 | $269 | $18 |
| Pioglitazone | 21 | $266 | $13 |
| Omeprazole | 39 | $250 | $6 |
| Atenolol | 44 | $241 | $5 |
| Lisinopril | 21 | $188 | $9 |
| Naproxen | 14 | $154 | $11 |
| Glipizide | 25 | $148 | $6 |
| Metoprolol | 12 | $140 | $12 |
| Hydrochlorothiazide | 25 | $114 | $5 |
| Ibuprofen | 13 | $72 | $6 |
| Cyclobenzaprine | 14 | $35 | $2 |
2015: 22 drugs
| Omega-3 Acid Ethyl Esters | 32 | $3,593 | $112 |
| Valsartan | 13 | $3,254 | $250 |
| Proair Hfa | 16 | $829 | $52 |
| Gabapentin | 17 | $680 | $40 |
| Levothyroxine | 37 | $657 | $18 |
| Amlodipine Besylate | 92 | $629 | $7 |
| Simvastatin | 67 | $621 | $9 |
| Metformin | 55 | $605 | $11 |
| Alendronate | 39 | $562 | $14 |
| Omeprazole | 29 | $391 | $13 |
| Hydrochlorothiazide | 54 | $315 | $6 |
| Atenolol | 47 | $259 | $6 |
| Losartan | 26 | $234 | $9 |
| Lisinopril | 31 | $221 | $7 |
| Glipizide Er | 12 | $219 | $18 |
| Hydralazine | 15 | $192 | $13 |
| Metoprolol | 16 | $157 | $10 |
| Ibuprofen | 18 | $139 | $8 |
| Naproxen | 11 | $110 | $10 |
| Famotidine | 16 | $93 | $6 |
| Glipizide | 17 | $87 | $5 |
| Hydrocortisone | 11 | $75 | $7 |
2014: 18 drugs
| Diovan | 14 | $3,275 | $234 |
| Metformin | 44 | $733 | $17 |
| Simvastatin | 56 | $654 | $12 |
| Levothyroxine | 41 | $561 | $14 |
| Isosorbide Mononitrate Er | 13 | $551 | $42 |
| Amlodipine Besylate | 69 | $518 | $8 |
| Lisinopril | 50 | $433 | $9 |
| Alendronate | 32 | $310 | $10 |
| Atenolol | 60 | $307 | $5 |
| Omeprazole | 20 | $289 | $14 |
| Clopidogrel | 13 | $262 | $20 |
| Hydrochlorothiazide | 19 | $225 | $12 |
| Glipizide Er | 12 | $152 | $13 |
| Hydrocodone-Acetaminophen | 12 | $149 | $12 |
| Zolpidem | 14 | $129 | $9 |
| Glipizide | 18 | $118 | $7 |
| Ranitidine | 11 | $98 | $9 |
| Ibuprofen | 12 | $62 | $5 |
2013: 13 drugs
| Diovan | 13 | $2,972 | $229 |
| Amlodipine Besylate | 57 | $479 | $8 |
| Isosorbide Mononitrate Er | 18 | $337 | $19 |
| Simvastatin | 39 | $329 | $8 |
| Lisinopril | 36 | $311 | $9 |
| Metformin | 28 | $299 | $11 |
| Levothyroxine | 20 | $201 | $10 |
| Atenolol | 27 | $200 | $7 |
| Tamsulosin | 11 | $157 | $14 |
| Alendronate | 21 | $135 | $6 |
| Hydrochlorothiazide | 13 | $107 | $8 |
| Hydrocodone-Acetaminophen | 17 | $101 | $6 |
| Glipizide | 11 | $57 | $5 |
Money from drug and device companies
$239 in 2025
| 2025 | 2 | 2 | None | $239 |
| 2022 | 2 | 2 | None | $34 |
| 2021 | 1 | 2 | None | $41 |
| 2019 | 2 | 2 | None | $175 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boehringer Ingelheim Pharmaceuticals | None | $124 | 1 payment
|
| Pfizer | Nurtec Odt | $115 | 1 payment
|
See all 2 published payments
| Pfizer | Meals · 2025-10-16 | Nurtec Odt | $115 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-25 | None | $124 |
See earlier years (2022, 2021, 2019)
2022: $34
| Pfizer | Prevnar 20 | $17 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 2 | $17 | 1 payment
|
2021: $41
| Novo Nordisk | Rybelsus | $41 | 2 payments
|
2019: $175
| Gilead Sciences | Vemlidy | $125 | 1 payment
|
| CooperSurgical | Paragard | $50 | 1 payment
|
Professional record
- NPI
- 1780829754
- Licence
- CA A106144California A106144: Current · expires 2028-01-31
- Trained
- University of California, San Francisco School of Medicine, 2009
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 15425 Los Gatos Blvd Ste 120, Los Gatos, CA, 95032
- NPI first listed
- 2008-12-04
- NPI last updated
- 2024-04-25
- NPI record certified
- 2024-04-25
This is when the NPI record was last certified, not a medical board exam.